CVS Health announced plans to separate its pharmacy business from its insurance and pharmacy benefit manager operations, aiming for completion by the first half of 2028. This decision comes after a previous consideration of a breakup was abandoned due to concerns about the viability of the retail pharmacy segment.
Analysts now believe that CVS's retail pharmacy, which includes around 9,000 locations, has become more profitable and stable, making it feasible to operate independently. CVS CEO David Joyner highlighted the company's turnaround, noting eight consecutive quarters of exceeding earnings expectations and a projected increase in operating cash flow to at least $15.5 billion by 2026.
Despite this progress, CVS's shares fell approximately 12% following the announcement, indicating investor skepticism. The retail pharmacy sector has benefited from competitors like Walgreens and Rite Aid reducing their footprints, allowing CVS to capture market share. However, the retail pharmacy remains a low-margin business, with operating margins around 4% to 5%.
Analysts suggest that the separation could clarify the value of CVS's more profitable insurance and pharmacy benefit management units, which have shown stronger growth. Regulatory pressures on pharmacy benefit managers may also have influenced the decision to separate, although CVS asserts that the split is based on strategic considerations rather than regulatory challenges.
The separation raises questions about the future of the commercial relationship between the pharmacy and insurance units, which historically benefited from shared resources and customer access. Overall, while the split may provide clarity and focus for each business, it introduces uncertainties regarding their interdependencies and operational efficiencies